 Biofrontera Inc BFRI has provided an update on the patient recruitment for the Phase 3 study for superficial basal cell carcinoma sBCC with Ameluz photodynamic therapy PDT combined with BF-RhodoLED lamp in the U.S. Thousands of new traders are learning the ins and outs on how to find profitable trades every day with Benzinga Trading School. Click Here Now to Start your FREE Trial. 